{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:11:28Z","timestamp":1793329888813,"version":"4.5.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T00:00:00Z","timestamp":1663113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007534","name":"B Braun","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100007534","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National institute for health research capability fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>We aimed to investigate the safety of drug-coated balloon (DCB)-only angioplasty compared to drug-eluting stent (DES), as part of routine clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The recent BASKETSMALL2 trial demonstrated the safety and efficacy of DCB angioplasty for de novo small vessel disease. Registry data have also demonstrated that DCB angioplasty is safe; however, most of these studies are limited due to long recruitment time and a small number of patients with DCB compared to DES. Therefore, it is unclear if DCB-only strategy is safe to incorporate in routine elective clinical practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We compared all-cause mortality and major cardiovascular endpoints (MACE), including unplanned target lesion revascularisation (TLR) of all patients treated with DCB or DES for first presentation of stable angina due to de novo coronary artery disease between 1st January 2015 and 15th November 2019. Data were analysed with Cox regression models and cumulative hazard plots.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We present 1237 patients; 544 treated with DCB and 693 treated with DES for de novo, mainly large-vessel coronary artery disease. On multivariable Cox regression analysis, only age and frailty remained significant adverse predictors of all-cause mortality. Univariable, cumulative hazard plots showed no difference between DCB and DES for either all-cause mortality or any of the major cardiovascular endpoints, including unplanned TLR. The results remained unchanged following propensity score-matched analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>DCB-only angioplasty, for stable angina and predominantly large vessels, is safe compared to DES as part of routine clinical practice, in terms of all-cause mortality and MACE, including unplanned TLR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphic abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1007\/s00392-022-02106-y","type":"journal-article","created":{"date-parts":[[2022,9,14]],"date-time":"2022-09-14T17:03:33Z","timestamp":1663175013000},"page":"1186-1193","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease in elective clinical practice"],"prefix":"10.1007","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2059-0357","authenticated-orcid":false,"given":"Ioannis","family":"Merinopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tharusha","family":"Gunawardena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Corballis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Bhalraam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clint","family":"Maart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisdair","family":"Ryding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toomas","family":"Sarev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Sawh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sreekumar","family":"Sulfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upul","family":"Wickramarachchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Wistow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed O.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamas A.","family":"Mamas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios S.","family":"Vassiliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon C.","family":"Eccleshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,14]]},"reference":[{"issue":"3","key":"2106_CR1","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"FJ Neumann","year":"2020","unstructured":"Neumann FJ, Sechtem U, Banning AP et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41(3):407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"issue":"9","key":"2106_CR2","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.jacc.2019.12.046","volume":"75","author":"C Yerasi","year":"2020","unstructured":"Yerasi C, Case BC, Forrestal BJ et al (2020) Drug-coated balloon for De Novo coronary artery disease: JACC state-of-the-art review. J Am Coll Cardiol 75(9):1061\u20131073. https:\/\/doi.org\/10.1016\/j.jacc.2019.12.046","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2106_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2174\/1573403X14666171226144120","volume":"14","author":"I Merinopoulos","year":"2018","unstructured":"Merinopoulos I, Gunawardena T, Wickramarachchi U, Ryding A, Eccleshall S, Vassiliou V (2018) Percutaneous coronary intervention in the elderly: are drug-coated balloons the future? Curr Cardiol Rev 14(1):45\u201352. https:\/\/doi.org\/10.2174\/1573403X14666171226144120","journal-title":"Curr Cardiol Rev"},{"issue":"12","key":"2106_CR4","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","volume":"13","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Eccleshall S, Wan Ahmad WA et al (2020) Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group. JACC Cardiovasc Interv 13(12):1391\u20131402. https:\/\/doi.org\/10.1016\/j.jcin.2020.02.043","journal-title":"JACC Cardiovasc Interv"},{"key":"2106_CR5","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1007\/s00392-020-01603-2","volume":"109","author":"G Fahrni","year":"2020","unstructured":"Fahrni G, Scheller B, Coslovsky M et al (2020) Drug-coated balloon versus drug-eluting stent in small coronary artery lesions: angiographic analysis from the BASKET-SMALL 2 trial. Clin Res Cardiol 109:1114\u20131124. https:\/\/doi.org\/10.1007\/s00392-020-01603-2","journal-title":"Clin Res Cardiol"},{"issue":"20","key":"2106_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0140-6736(20)32173-5","volume":"6736","author":"RV Jeger","year":"2020","unstructured":"Jeger RV, Farah A, Ohlow M-A et al (2020) Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial. Lancet 6736(20):1\u20137. https:\/\/doi.org\/10.1016\/s0140-6736(20)32173-5","journal-title":"Lancet"},{"issue":"18","key":"2106_CR7","first-page":"1","volume":"6736","author":"RV Jeger","year":"2018","unstructured":"Jeger RV, Farah A, Ohlow M et al (2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 6736(18):1\u20138","journal-title":"Lancet"},{"issue":"2","key":"2106_CR8","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00392-020-01674-1","volume":"110","author":"RV Jeger","year":"2021","unstructured":"Jeger RV, Kaiser C, Mangner N, Kleber FX, Scheller B (2021) Causes of death after treatment of small coronary artery disease with paclitaxel-coated balloons. Clin Res Cardiol 110(2):307\u2013311. https:\/\/doi.org\/10.1007\/s00392-020-01674-1","journal-title":"Clin Res Cardiol"},{"issue":"3","key":"2106_CR9","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s00392-018-1346-8","volume":"108","author":"X Yu","year":"2019","unstructured":"Yu X, Xu F, Zhang W et al (2019) Treatment of large de novo coronary lesions with paclitaxel-coated balloon only: results from a Chinese institute. Clin Res Cardiol 108(3):234\u2013243. https:\/\/doi.org\/10.1007\/s00392-018-1346-8","journal-title":"Clin Res Cardiol"},{"issue":"2","key":"2106_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00392-020-01734-6","volume":"110","author":"I Merinopoulos","year":"2021","unstructured":"Merinopoulos I, Gunawardena T, Wickramarachchi U et al (2021) Long-term safety of paclitaxel drug-coated balloon-only angioplasty for de novo coronary artery disease: the SPARTAN DCB study. Clin Res Cardiol 110(2):220\u2013227. https:\/\/doi.org\/10.1007\/s00392-020-01734-6","journal-title":"Clin Res Cardiol"},{"issue":"9","key":"2106_CR11","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1253\/circj.CJ-15-0264","volume":"79","author":"TK Park","year":"2015","unstructured":"Park TK, Park YH, Song YB et al (2015) Long-term clinical outcomes of true and non-true bifurcation lesions according to medina classification\u2014results from the COBIS (COronary BIfurcation stent) II registry. Circ J 79(9):1954\u20131962. https:\/\/doi.org\/10.1253\/circj.CJ-15-0264","journal-title":"Circ J"},{"issue":"24","key":"2106_CR12","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1161\/CIRCULATIONAHA.117.029289","volume":"137","author":"HM Garcia-Garcia","year":"2018","unstructured":"Garcia-Garcia HM, McFadden EP, Farb A et al (2018) Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document. Circulation 137(24):2635\u20132650. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029289","journal-title":"Circulation"},{"issue":"10132","key":"2106_CR13","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","volume":"391","author":"T Gilbert","year":"2018","unstructured":"Gilbert T, Neuburger J, Kraindler J et al (2018) Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet 391(10132):1775\u20131782. https:\/\/doi.org\/10.1016\/S0140-6736(18)30668-8","journal-title":"Lancet"},{"issue":"2","key":"2106_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.3329\/cardio.v3i2.9198","volume":"3","author":"Z Rahman","year":"2011","unstructured":"Rahman Z, Ullah M, Choudhury A (2011) Coronary artery dissection and perforation complicating percutaneous coronary intervention\u2014a review. Cardiovasc J 3(2):239\u2013247. https:\/\/doi.org\/10.3329\/cardio.v3i2.9198","journal-title":"Cardiovasc J"},{"issue":"2","key":"2106_CR15","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","volume":"40","author":"FJ Neumann","year":"2019","unstructured":"Neumann FJ, Sousa-Uva M, Ahlsson A et al (2019) 2018 ESC\/EACTS Guidelines on myocardial revascularization. Eur Heart J 40(2):87\u2013165. https:\/\/doi.org\/10.1093\/eurheartj\/ehy394","journal-title":"Eur Heart J"},{"issue":"5","key":"2106_CR16","doi-asserted-by":"publisher","first-page":"E317","DOI":"10.1002\/ccd.27548","volume":"92","author":"D Venetsanos","year":"2018","unstructured":"Venetsanos D, Lawesson SS, Panayi G et al (2018) Long-term efficacy of drug coated balloons compared with new generation drug-eluting stents for the treatment of de novo coronary artery lesions. Catheter Cardiovasc Interv 92(5):E317\u2013E326. https:\/\/doi.org\/10.1002\/ccd.27548","journal-title":"Catheter Cardiovasc Interv"},{"key":"2106_CR17","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6548696","author":"M Rosenberg","year":"2019","unstructured":"Rosenberg M, Waliszewski M, Krackhardt F et al (2019) Drug coated balloon-only strategy in de Novo Lesions of Large Coronary Vessels. J Interv Cardiol. https:\/\/doi.org\/10.1155\/2019\/6548696","journal-title":"J Interv Cardiol."},{"issue":"1","key":"2106_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/ccd.28217","volume":"95","author":"I Merinopoulos","year":"2020","unstructured":"Merinopoulos I, Wickramarachchi U, Wardley J et al (2020) Day case discharge of patients treated with drug coated balloon only angioplasty for de novo coronary artery disease\u202f: a single center experience. Catheter Cardiovasc Interv 95(1):105\u2013108. https:\/\/doi.org\/10.1002\/ccd.28217","journal-title":"Catheter Cardiovasc Interv"},{"key":"2106_CR19","unstructured":"Ludman PF. BCIS Audit returns adult interventional procedures. Published 2019. Accessed October 28, 2019. http:\/\/www.bcis.org.uk\/wp-content\/uploads\/2019\/02\/BCIS-Audit-2017-18-data-for-web-ALL-excl-TAVI-as-27-02-2019.pdf"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-022-02106-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-022-02106-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T14:12:12Z","timestamp":1692886332000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-022-02106-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,14]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2106"],"URL":"https:\/\/doi.org\/10.1007\/s00392-022-02106-y","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,14]]},"assertion":[{"value":"20 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"VSV received honoraria for speaking at conferences by Daiichi Sankyo and Novartis and a research grant from B Braun for investigator-initiated research. SCE received research grants for investigator-initiated research and lecture honoraria from B Braun. He also acts as a consultant for B Braun, Medtronic and MedAlliance. The other authors have nothing to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study received approval from Northwest Haydock research ethics committee and institutional approval from the Norfolk & Norwich University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was not deemed necessary according to Confidentiality Advisory Group (17\/CAG\/0145).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}